Literature DB >> 28674151

Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability.

Edmund H Wilkes1, Pedro Casado1, Vinothini Rajeeve1, Pedro R Cutillas2.   

Abstract

Cell survival is regulated by a signaling network driven by the activity of protein kinases; however, determining the contribution that each kinase in the network makes to such regulation remains challenging. Here, we report a computational approach that uses mass spectrometry-based phosphoproteomics data to rank protein kinases based on their contribution to cell regulation. We found that the scores returned by this algorithm, which we have termed kinase activity ranking using phosphoproteomics data (KARP), were a quantitative measure of the contribution that individual kinases make to the signaling output. Application of KARP to the analysis of eight hematological cell lines revealed that cyclin-dependent kinase (CDK) 1/2, casein kinase (CK) 2, extracellular signal-related kinase (ERK), and p21-activated kinase (PAK) were the most frequently highly ranked kinases in these cell models. The patterns of kinase activation were cell-line specific yet showed a significant association with cell viability as a function of kinase inhibitor treatment. Thus, our study exemplifies KARP as an untargeted approach to empirically and systematically identify regulatory kinases within signaling networks.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28674151      PMCID: PMC5587867          DOI: 10.1074/mcp.O116.064360

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  44 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  A self-validating quantitative mass spectrometry method for assessing the accuracy of high-content phosphoproteomic experiments.

Authors:  Pedro Casado; Pedro R Cutillas
Journal:  Mol Cell Proteomics       Date:  2010-10-24       Impact factor: 5.911

3.  PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.

Authors:  Edita Aksamitiene; Boris N Kholodenko; Walter Kolch; Jan B Hoek; Anatoly Kiyatkin
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

4.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

5.  Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data.

Authors:  Karen A Ryall; Jimin Shin; Minjae Yoo; Trista K Hinz; Jihye Kim; Jaewoo Kang; Lynn E Heasley; Aik Choon Tan
Journal:  Bioinformatics       Date:  2015-07-23       Impact factor: 6.937

6.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

7.  Kinase requirements in human cells: I. Comparing kinase requirements across various cell types.

Authors:  Dorre A Grueneberg; Sebastien Degot; Joseph Pearlberg; Wenliang Li; Joan E Davies; Amy Baldwin; Wilson Endege; John Doench; Jacqueline Sawyer; Yanhui Hu; Frederick Boyce; Jun Xian; Karl Munger; Ed Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-23       Impact factor: 11.205

8.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

9.  An atlas of human kinase regulation.

Authors:  David Ochoa; Mindaugas Jonikas; Robert T Lawrence; Bachir El Debs; Joel Selkrig; Athanasios Typas; Judit Villén; Silvia Dm Santos; Pedro Beltrao
Journal:  Mol Syst Biol       Date:  2016-12-01       Impact factor: 11.429

10.  Phosphorylation networks regulating JNK activity in diverse genetic backgrounds.

Authors:  Chris Bakal; Rune Linding; Flora Llense; Elleard Heffern; Enrique Martin-Blanco; Tony Pawson; Norbert Perrimon
Journal:  Science       Date:  2008-10-17       Impact factor: 47.728

View more
  9 in total

Review 1.  Mouse models of growth hormone deficiency.

Authors:  Edward O List; Reetobrata Basu; Silvana Duran-Ortiz; Jackson Krejsa; Elizabeth A Jensen
Journal:  Rev Endocr Metab Disord       Date:  2020-10-09       Impact factor: 6.514

2.  The temporal profile of activity-dependent presynaptic phospho-signalling reveals long-lasting patterns of poststimulus regulation.

Authors:  Kasper Engholm-Keller; Ashley J Waardenberg; Johannes A Müller; Jesse R Wark; Rowena N Fernando; Jonathan W Arthur; Phillip J Robinson; Dirk Dietrich; Susanne Schoch; Mark E Graham
Journal:  PLoS Biol       Date:  2019-03-01       Impact factor: 8.029

3.  INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases.

Authors:  Robin Beekhof; Carolien van Alphen; Alex A Henneman; Jaco C Knol; Thang V Pham; Frank Rolfs; Mariette Labots; Evan Henneberry; Tessa Ys Le Large; Richard R de Haas; Sander R Piersma; Valentina Vurchio; Andrea Bertotti; Livio Trusolino; Henk Mw Verheul; Connie R Jimenez
Journal:  Mol Syst Biol       Date:  2019-04-12       Impact factor: 11.429

4.  Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome.

Authors:  Mariette Labots; Thang V Pham; Richard J Honeywell; Jaco C Knol; Robin Beekhof; Richard de Goeij-de Haas; Henk Dekker; Maarten Neerincx; Sander R Piersma; Johannes C van der Mijn; Donald L van der Peet; Martijn R Meijerink; Godefridus J Peters; Nicole C T van Grieken; Connie R Jiménez; Henk M W Verheul
Journal:  Cancers (Basel)       Date:  2020-02-01       Impact factor: 6.639

5.  Robust inference of kinase activity using functional networks.

Authors:  Serhan Yılmaz; Marzieh Ayati; Daniela Schlatzer; A Ercüment Çiçek; Mark R Chance; Mehmet Koyutürk
Journal:  Nat Commun       Date:  2021-02-19       Impact factor: 17.694

6.  eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors.

Authors:  Maruan Hijazi; Pedro Casado; Nosheen Akhtar; Saul Alvarez-Teijeiro; Vinothini Rajeeve; Pedro R Cutillas
Journal:  Mol Cell Proteomics       Date:  2022-05-02       Impact factor: 7.381

7.  KSTAR: An algorithm to predict patient-specific kinase activities from phosphoproteomic data.

Authors:  Sam Crowl; Ben T Jordan; Hamza Ahmed; Cynthia X Ma; Kristen M Naegle
Journal:  Nat Commun       Date:  2022-07-25       Impact factor: 17.694

8.  Proteomics and phosphoproteomics in precision medicine: applications and challenges.

Authors:  Girolamo Giudice; Evangelia Petsalaki
Journal:  Brief Bioinform       Date:  2019-05-21       Impact factor: 11.622

9.  Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA).

Authors:  Mahmoud Hallal; Sophie Braga-Lagache; Jovana Jankovic; Cedric Simillion; Rémy Bruggmann; Anne-Christine Uldry; Ramanjaneyulu Allam; Manfred Heller; Nicolas Bonadies
Journal:  BMC Cancer       Date:  2021-07-08       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.